Picture of Pharvaris NV logo

PHVS Pharvaris NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Pharvaris NV reports results for the quarter ended in September - Earnings Summary

* Pharvaris NV  PHVS.OQ  reported a quarterly adjusted loss
of 25
cents​​ per share for the quarter ended in September. The mean
expectation of five analysts for the quarter was for a loss
of 63 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Pharvaris NV's reported EPS for the quarter was a loss
of 25
cents​.
    * The mean earnings estimate of analysts had fallen by
about 9.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Pharvaris NV shares had fallen by 67.3% this quarter and
lost 82.6% so far this year.
    * The company reported a quarterly loss of €8.49 million.
    * Wall Street's median 12-month price target for Pharvaris
NV is
$18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data December
8 at 12:35 p.m.  ​All figures in euros unless otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.63          -0.25          Beat
 Jun. 30 2022      -0.56          -0.38          Beat
 Mar. 31 2022      -0.49          -0.48          Beat
 Dec. 31 2021      -0.71          -0.09          Beat

Recent news on Pharvaris NV

See all news